[ABSTRACT] 24
Introduction
Necrotizing fasciitis, commonly known as the "flesh-eating disease", is an 48 invasive infection with very high rates of human morbidity and mortality (1, 2) . In 49 severe cases, contiguous muscle may be severely damaged, resulting in 50 necrotizing myositis. Based on whether the cause is polymicrobial or 51 monomicrobial, necrotizing fasciitis can be divided into type I (polymicrobial) and 52 type II (monomicrobial) (2, 3). Group A streptococcus (GAS) is the primary cause 53 of type II necrotizing fasciitis, and has an average case fatality rate of 29% (2, 4, 54 5) . The molecular pathogenesis processes at work in GAS necrotizing fasciitis 55 and myositis are poorly understood, a lack of knowledge that has impeded 56 development of new effective diagnostics and therapeutics. 57 GAS is a human-specific pathogen causing more than 700 million 58 infections annually worldwide (6). GAS infections range from relatively benign 59 pharyngitis, skin, and soft-tissue infections, to life-threatening invasive diseases 60 such as necrotizing fasciitis and necrotizing myositis (1, 7) . No vaccine is 61 currently available to prevent GAS infections. Decades of research have 62 strains have wild-type alleles of all major transcriptional regulators that are known 116 to affect GAS virulence, such as covR and covS, ropB, mga, and rocA, and (iv) 117 both strains have been used previously in animal infection studies (18, 20, 33) . 118
Using transposon plasmid pGh9:ISS1 (49), we generated dense transposon 119 mutant libraries in strains MGAS2221 and MGAS27961 containing 154,666 (an 120 insertion every 12 bp on average) and 330,477 (an insertion every 5.5 bp on 121 average) unique transposon insertions, respectively ( Figure 1A) . This means 122 that on average, the serotype M1 and M28 libraries had 66 and 139 insertions 123 per open reading frame. The insertion index (number of unique insertions/size of 124 the gene) of each of the genes in the M1 and M28 genomes is illustrated in 125 Figure 1B . Use of the MGAS2221 transposon mutant library to identify novel 126 genes contributing to GAS fitness in human saliva ex vivo has been described 127 recently (31). 128
Genome-wide screens identify GAS genes contributing to fitness in a 129 necrotizing myositis infection model in cynomolgus macaques. We screened the 130 M1 and M28 GAS transposon mutant libraries in NHPs as a first step toward 131 discovering genes contributing to fitness during necrotizing myositis. Six 132 cynomolgus macaques each were inoculated by intramuscular injection with 133 either the M1 or M28 transposon mutant libraries and followed for 24 h. All 134 animals developed signs and symptoms consistent with necrotizing myositis and 135 were necropsied. Biopsies containing necrotic muscle were obtained from the 136 inoculation site to recover output mutant pools for subsequent analysis.
Quantitative culture yielded an average of 4.87 x 10 8 CFU/g for M1, and 8.77 x 138 10 8 for M28 in the tissue biopsy specimens used for TraDIS analysis. 139
TraDIS was used to compare the mutant compositions of the input and 140 output pools. The TraDIS analysis identified genes with significantly altered 141 mutant frequency in the output mutant pools relative to the input mutant pool 142 (examples shown in Figure S1 ). Infection bottlenecks can be a technical 143 challenge for high-throughput transposon mutagenesis studies, and substantial 144 loss of mutant library complexity during animal infection can result in erroneous 145 identification of fitness genes (50). Our TraDIS results showed that for both M1 146 and M28 GAS screens, there was no substantial decline of mutant library 147 complexity post NHP infections (Figure 2A,B ). On average, 67% and 84% of the 148 library complexity remain in the M1 and M28 output pools, respectively ( Figure  149 2A,B). This high diversity of transposition site mutants recovered is inconsistent 150 with a narrow infection bottleneck and indicates that our screens are unlikely to 151 erroneously identify fitness genes. To identify GAS fitness genes in the infected 152 NHP skeletal muscle milieu, genes previously identified as essential for GAS 153 growth in vitro in rich medium (THY) were excluded from the analysis as is 154 commonly done (51). Disrupted genes associated with significantly decreased 155 fitness (transposon frequency log2 fold-change < -1, and q value < 0.01) in the 156 output mutant pools were interpreted as contributing to NHP necrotizing myositis 157 ( Figure 2C ,D, Figure 3 ). We identified 126 and 116 genes in the serotype M1 and 158 M28 strains, respectively, that are crucial for GAS fitness in this infection model 159 ( Figure 3A ). That is, inactivating these genes potentially confers diminished GAS 160 fitness in necrotizing myositis. Importantly, a common set of 72 genes was 161 identified as crucial for fitness in both the serotype M1 and M28 library NHP 162 screens ( Figure 3A , Table S1 ). The shared 72 genes represent 57% of the 163 serotype M1 fitness genes and 65% of the serotype M28 fitness genes ( Figure  164 3A). Functional categorization of the fitness genes found that numerically, the 165 more prevalent GOG categories included genes inferred to be involved in amino 166 acid transport and metabolism (E), inorganic ion transport and metabolism (P), 167 and transcription (K) ( Figure 3C ). Genes encoding many documented virulence 168 factors or virulence modulating factors were identified as contributing to fitness in 169 both serotype M1 and M28 GAS strains, including adcB/C (52, 53), gacI (54, 55), 170 pepO (56, 57), inlA (58), perR (59) and scfAB (32) ( Table S1, Table S2 , Table  171 S4). 172
We also identified 21 and 20 genes in the serotype M1 and M28 strains, 173 respectively, that are associated with significantly increased fitness in vivo 174 (transposon insertion frequency log2 fold-change > 1, and q value < 0.01) ( Figure  175 2, Figure 3B and 3D). That is, inactivating these genes potentially confers 176 enhanced GAS fitness during NHP necrotizing myositis. These genes include 177 known negative regulators of virulence rivR (60) and rocA (61-65). Of note, rocA 178 and ppiB (peptidyl-prolyl cis-trans isomerase) were identified in both the serotype 179 M1 and M28 strains ( Figure 3B , Table S3 , Table S5 ). Inactivation of the rocA 180 gene in an M28 GAS strain was recently shown to significantly increase virulence 181 in a mouse model of necrotizing myositis (66).
To investigate the phylogenetic distribution of the identified in vivo fitness 183 genes among diverse GAS strains, we examined the presence of M1 and M28 184 fitness genes required during NHP necrotizing myositis in 62 sequenced GAS 185 genomes representing 26 different M protein serotypes (Table S6 ). The vast 186 majority of the M1 fitness genes (96%) and M28 fitness genes (93%) are present 187 in at least 61 of the 62 GAS strains (Figure 3, E and F) . 188
Comparison of the genetic requirement for necrotizing myositis and those 189 for GAS fitness in human saliva and blood ex vivo, and mouse subcutaneous 190 infections. Previous genome-wide transposon mutagenesis studies identified 191 GAS genes required for growth in animal infection models and ex vivo in human 192 body fluids such as blood and saliva (30-32). These published data allowed us to 193 test the hypothesis that the GAS gene requirements for NHP necrotizing myositis 194 are distinct from those identified by transposon screens performed in other model 195 infection environments. That is, we were able to assess the extent to which GAS 196 has infection-specific genetic programs. We recently reported that 92 serotype 197 M1 genes were required for optimal growth ex vivo in human saliva (31). Only 19 198 (21% of 92) genes were defined as contributing to serotype M1 fitness in both 199 human saliva and NHP necrotizing myositis ( Figure 4A ). These genes include 200 metabolic genes (purA, purB, acoABCL, glgP and malM) and transporter genes 201 (adcAB, braB, mtsA, mtsB, artP, and artQ) . The great majority of M1 genes (n = 202 107, 85%) required in NHP necrotizing myositis did not overlap with fitness 203 genes required ex vivo in human saliva. Using a similar transposon mutagenesis 204 technique (Tn-seq) 147 genes were identified as contributing to fitness of 205 serotype M1 GAS strain 5448 after subcutaneous inoculation in mice (32). The 206 overlap between the mouse subcutaneous fitness genes and the 126 necrotizing 207 myositis genes is relatively larger (n = 39) ( Figure 4B ). These genes include 208 metabolic genes purA, purB, acoABCL, glgP, malM, arcABCD, and 209 phosphotransferase system genes manMLN. However, 69% of the genes (n = 210 87) required for NHP necrotizing myositis did not overlap with the genes 211 identified in the mouse subcutaneous infection study. Using a transposon 212 mutagenesis technique, Mclver and colleagues (30) identified 81 M1 GAS genes 213 required for optimal bacterial growth in human blood. In comparison with the 126 214 necrotizing myositis fitness genes, only 14 genes were required in both 215 conditions ( Figure 4C ). 89% of the genes (n = 112) required for NHP necrotizing 216 myositis did not overlap with the genes required in human blood ex vivo. These 217 include genes for carbohydrate metabolism (glgP, malM), transporters (adcB, 218 braB, mtsA, mtsB) , and transcriptional regulators (adcR, ciaH, ciaR, ihk, irr) . To 219 summarize, there is only modest overlap between the GAS genes contributing to 220 fitness during experimental NHP necrotizing myositis, relative to growth ex vivo in 221 human saliva and blood, and mouse subcutaneous infection. These results are 222 consistent with our hypothesis that GAS has infection-specific genetic programs. 223
Genes encoding transporters constitute a considerable portion of GAS 224 fitness determinants in experimental NHP necrotizing myositis. Bioinformatic 225 analyses of the identified fitness genes found that regardless of M1 or M28 226 serotype, more than 25% of the genes contributing to in vivo fitness during NHP 227 necrotizing myositis encode proven or putative transporters ( Figure 5A ). 228
Specifically, 25.4 % of the serotype M1 fitness genes (n = 32) and 29.7% of the 229 M28 GAS fitness genes (n = 32) encode proven or putative transporters ( Figure  230 5A). Importantly, 26 transporter genes are required in both M1 and M28 strains 231 during infection, indicating that there was considerable overlap between the two 232 sets of genes ( Figure 5B ). These 26 shared genes encode 13 distinct 233 transporters with proven or predicted roles in uptake of nutrients such as amino 234 acids, metal ions, vitamins, carbohydrate, and export of a variety of substrates. 235
( Figure 5C ). The DNA sequences of the 26 transporter genes are highly 236 conserved (95% to 100% identity) among genomes for 62 sequenced GAS 237 strains representing 26 different M protein serotypes ( Figure 6 ). One gene 238 (Spy0499) has less homology in GAS (81% identical in four GAS strains) among 239 the 62 strains with complete genomes. To test the hypothesis that Spy0014, BraB, and Spy0271-0273 participate 250 in amino acid transport, we constructed isogenic deletion mutant strains ΔSpy0014, ΔbraB, and ΔSpy0271-0273 in parental M1 strain MGAS2221. We 252 studied their growth phenotypes in rich medium (THY broth), and in a peptide-253 free chemically defined medium (CDM) (Figure 7 ). Compared to the wild-type 254 parental strain, the three isogenic mutant strains do not have a growth defect in 255 THY medium ( Figure 7A ). However, the mutant strains had a severe growth 256 defect when cultured in CDM ( Figure 7B ), a result consistent with our hypothesis. 257
As anticipated, the growth defect of these three isogenic mutant strains 258 ΔSpy0014, ΔbraB, and ΔSpy0271-0273 was ameliorated by supplementing CDM 259 with 0.1 g/ml tryptone, a source of abundant peptides ( Figure 7C ). Together, 260
these results are consistent with the idea that Spy0014, BraB, and Spy0271-261 0273 are amino acid transporters that are essential for GAS growth in the 262 absence of a source of abundant exogenous peptides. 263 GAS is auxotrophic for 15 amino acids considered essential for growth 264 (68, 69). We hypothesized that transporters Spy0014, BraB and Spy0271-0273 265 contribute to uptake of specific essential amino acids. To test this hypothesis, we 266 supplemented CDM with a high concentration (1 g/L) of each of the highly 267 soluble essential amino acids to determine if certain amino acids restored the 268 growth of these transporter mutants via non-specific uptake ( Figure 7D -F). 269
Consistent with the hypothesis, supplementing CDM with methionine restored the 270 growth of mutant ΔSpy0271-0273 to near-wild-type growth phenotype, 271
suggesting that Spy0271-0273 encode a methionine transporter ( Figure 7E ). 272
Similarly, supplementing CDM with histidine and valine partially restored the 273 growth of mutant strains ΔSpy0014 and ΔbraB, respectively, suggesting that 274 Virulence role of Spy1726-1728, a poorly characterized ABC transporter. 286
Our genome-wide screens identified a putative ABC transporter of unknown 287 function that is required for NHP infection by the M1 and M28 GAS strains 288 ( Figure 5C , red). This putative transporter is encoded by three contiguous genes: 289 Spy1726 (transporter permease protein), Spy1727 (ATP-binding protein), and 290
Spy1728 (substrate-binding lipoprotein). To confirm the virulence role of this 291 putative transporter, we used isogenic mutant strain ΔSpy1726-1728 made by 292 deleting the entire Spy1726-1728 region in serotype M1 parental strain 293
MGAS2221. Consistent with the result from the initial NHP necrotizing myositis 294
TraDIS screen, isogenic mutant strain ΔSpy1726-1728 is significantly attenuated 295 in capacity to cause necrotizing myositis in NHPs (Figure 8 , A -D). This putative 296 ABC transporter operon was not identified as important for virulence in previous 297 GAS transposon mutagenesis screens (24, 30, 32) , suggesting an infection-or 298 primate-specific role in necrotizing myositis. Of note, Spy1728 (a substrate-299 binding lipoprotein) was previously shown to be a GAS surface protein and 300 potential vaccine candidate (70). 301
Virulence role of quorum sensing peptide transporter PptAB. Our genome-302
wide TraDIS screens suggest that inactivating the quorum sensing peptide 303
transporter PptAB in the serotype M1 and M28 strains results in significantly 304 decreased fitness in NHP necrotizing myositis. To test this finding, we generated 305 isogenic mutant strain ΔpptAB by deleting the pptAB genes in serotype M1 306 parental strain MGAS2221. Relative to the WT parental strain, the ΔpptAB 307 mutant strain is significantly attenuated in ability to cause necrotizing myositis in 308 NHPs (Figure 8 , A-D). PptAB has been reported to be required for exporting the 309 SHP2 and SHP3 quorum sensing peptides (71). However, Rgg2, the 310 transcriptional regulator that controls expression of the shp2 and shp3 genes was 311 not identified as important for NHP infections in our TraDIS screens. These 312 results suggest the attenuation of the virulence phenotype in the ΔpptAB mutant 313 strain is likely not associated with the SHP2, SHP3 quorum-sensing pathway in 314 serotype M1 and M28 strains in this infection model. 315
Confirmation of the virulence role of glgP, a gene involved in 316 carbohydrate utilization. Our TraDIS screens identified many GAS genes 317 implicated in transport of nutrients such as amino acids, vitamins and 318 carbohydrates. We next studied a gene likely to be involved in carbohydrate 319 utilization. The GAS gene glgP was identified as essential for necrotizing myositis 320 in the TraDIS screens conducted with both the serotype M1 and M28 transposon 321 mutant libraries (Table S1 ). However, glgP has not previously been implicated in 322 GAS virulence. glgP encodes an inferred protein with homology to E. coli 323 glycogen phosphorylase (72). We generated isogenic mutant strain ΔglgP by 324 deleting the glgP gene in serotype M1 strain MGAS2221. The ΔglgP isogenic 325 mutant strain is severely attenuated in capacity to cause necrotizing myositis in 326
NHPs, thereby confirming the TraDIS screen finding (Figure 8 , A-D). We next 327 evaluated the potential role of glgP in carbohydrate metabolism. Although the 328
ΔglgP mutant strain has no growth defect in medium with glucose, this mutant 329 strain has a severe growth defect when maltose or maltodextrin is provided as 330 the sole carbohydrate in the culture medium ( Figure 9 , A-C). Consistent with the 331 idea that the product of the glgP gene is involved in glycogen and starch 332 utilization, bacteria grown in THY supplemented with starch showed evidence of 333 starch accumulation in the isogenic mutant strain ΔglgP, but not the wild-type 334 parental strain that retains the ability to metabolize starch ( Figure 9D ). 335
Interestingly, in E. coli, glycogen accumulation is also significantly higher in glgP 336 deletion mutants (72). 337
Expression of the GAS genes implicated in in vivo fitness genes during 338 NHP necrotizing myositis. In the aggregate, data from the in vivo transposon 339 mutant library screens and analysis of the isogenic mutant strains imply that the 340 genes identified are expressed during NHP necrotizing myositis. To directly test 341 for expression in vivo, we used TaqMan qRT-PCR to measure the transcript level 342 of GAS transporter genes Spy0014, Spy0271, braB, Spy1726, pptA, and metabolic gene glgP in the NHP muscle tissue infected with M1 GAS 344 MGAS2221. The transcript of all six of the GAS fitness genes studied were 345 detectable by TaqMan qRT-PCR, thereby confirming that these genes are 346 expressed in vivo in NHP necrotizing myositis ( Figure 10A ). 347
Expression of fitness genes in vivo in a human with necrotizing myositis. 348
We next tested the hypothesis that the six targeted genes of interest are 349 expressed in a human patient with necrotizing myositis. Necrotic skeletal muscle 350 obtained from a patient with culture-proven GAS infection was studied by 351
TaqMan qRT-PCR. The results confirmed the presence of transcripts from the 352 six genes in the infected human patient ( Figure 10B ). Important to note, the 353 relative transcript levels for all genes tested were closely similar in the 354 experimentally infected NHPs and humans with natural infection. 
Discussion

358
GAS is an abundant human pathogen that is responsible for substantial human 359 illness and economic loss worldwide. Necrotizing fasciitis and myositis caused 360 by this organism are particularly devastating infections because they have high 361 morbidity and mortality. Effective treatment options for these infections remain 362 limited and a licensed human GAS vaccine is not available. Thus, a fuller 363 understanding of pathogen factors that contribute to these severe diseases is 364
warranted and may facilitate translational research activities. 365
Our genome-wide screens identified 126 M1 genes and 116 M28 genes 366 contributing to fitness in NHP necrotizing myositis. Of particular importance, we 367 discovered a significant overlap between the genes identified in the M1 and M28 368 in vivo fitness screens, with 72 genes common to both serotypes, representing 369 57% and 64% of the M1 and M28 fitness genes, respectively. The similarity 370 between M1 and M28 in vivo fitness gene results suggests the existence of 371 conserved programs used by multiple diverse GAS strains to proliferate and 372 damage tissue in necrotizing myositis. Many of the shared 72 genes encode 373 proven or putative metabolic enzymes implicated in complex carbohydrate 374 metabolism (malM and glgP), pyruvate metabolism (acoA, acoB, acoL), amino 375 acid biosynthesis (tkt, aroD, glnA, and arcB), and nucleotide biosynthesis (purA 376 and purB), suggesting these pathways are critical for GAS fitness in the 377 environment of deep-tissue infection. In addition to metabolic genes, several 378 previously identified GAS virulence or fitness factors were also among the 72 379 genes. For example, ScfAB (two putative membrane proteins) were identified as 380 important for GAS fitness and virulence during subcutaneous infection in mice 381 (32). adcABC (zinc importer) is critical for GAS virulence in mice and has vaccine 382 interest (52). 383
In contrast to the similar critical gene requirements for serotype M1 and 384 M28 GAS during experimental NHP necrotizing myositis, there is relatively little 385 overlap between M1 GAS genes required for necrotizing myositis and growth in 386 human saliva ex vivo (Figure 4) . That is, the spectrum of genes contributing to 387 fitness in these two environments is largely distinct. For example, genes 388 encoding multiple amino acid transporters (e.g., Spy0014, braB and sstT) 389 required for GAS fitness during necrotizing myositis were not identified as 390 important for growth ex vivo in human saliva ( Figure 4A) . In contrast, a GAS 391 phosphate transporter encoded by the pst operon is essential for persistence in 392 human saliva ex vivo but is apparently dispensable for NHP muscle infection 393 ( Figure 4A) . These results suggest that amino acid uptake is critical for GAS 394 fitness during muscle infections, whereas phosphate uptake is essential for 395 growth in human saliva ex vivo. Similarly, GAS genes contributing to NHP 396 necrotizing myositis and mouse subcutaneous infection also have relatively little 397 overlap ( Figure 4B ). Many GAS metabolic genes are specifically required for 398 NHP necrotizing myositis. For example, genes for de novo purine nucleotide 399 biosynthesis (purA and purB), carbohydrate utilization (glgP and malM), and 400 arginine and citrulline catabolism (arcABCD) are uniquely important for NHP 401 necrotizing myositis. Moreover, several known streptococcal virulence-402 modulating factors were also identified in NHP necrotizing myositis. These 403 include genes for GAS lipoprotein processing (lgt and lsp) (73-75), and genes for 404 a two-component regulatory system that is essential for GAS to evade human 405 innate immunity (ihk and irr) (76, 77) ( Figure 4B ). Taken together, these results 406 suggest the nutritional environment and the survival pressures present in the 407 infected NHP skeletal muscle are distinct from those in human saliva ex vivo and 408 in a mouse subcutaneous infection model. These results imply that complex 409 gene programs used by GAS to cause other types of human infections (e.g., 410
puerperal sepsis and pharyngitis) are also likely to be niche-specific. 411
A key theme of our M1 and M28 NHP genome-wide screens was 412 identification of many genes encoding transporters that are required during 413 necrotizing myositis. Pinpointing exactly which of the transporters contribute to 414 bacterial virulence during necrotizing myositis sheds new light on the 415 mechanisms of GAS-host interactions in this severe infection. We identified 13 416 distinct transporters that are required in both M1 and M28 GAS strains. Six of 417 these transporters are inferred to function in amino acid transport. This 418 observation suggests the ability to efficiently acquire host amino acids is critical 419 for the pathogenesis of GAS necrotizing myositis. In vitro growth assays showed 420 that amino acid transporter mutant strains ΔSpy0014, ΔbraB, and ΔSpy0271-421 0273 have a significant growth defect in the peptide-free CDM that is ameliorated 422 by supplementing CDM with tryptone, a source of abundant peptides. These 423 results suggest that efficient amino acid uptake is critical for wild-type GAS 424 growth when the peptide source is limited, and the nutritional environment of the 425 infected muscle is probably a poor source of available peptides. GAS 426 is auxotrophic for 15 amino acids considered essential for growth (68). We 427 hypothesized that transporters Spy0014, BraB and Spy0271-0273 are required 428 for the highly efficient uptake of certain essential amino acids. As anticipated, we 429 showed that supplementing CDM with methionine, histidine, and valine restored 430 the growth of mutant strains ΔSpy0271-0273, ΔSpy0014 and 431 ΔbraB, respectively, indicating these three transporters contribute to transport of 432 these three amino acids. Interestingly, the concentration of free methionine, 433 histidine, and valine in the human skeletal muscle tissue are 16.4 mg/L, 57.4 mg/L, and 30.5 mg/L, values lower than those present in CDM (100 mg/L) (78, 435 79). In the aggregate, our results suggest efficient uptake of essential host amino 436 acids such as methionine, histidine, and valine is important for GAS to cause 437 necrotizing myositis in NHPs. The qRT-PCR data demonstrating the presence of 438 transcripts from these transporter genes document that they are expressed in 439
NHPs and infected humans. Together, this implies that blocking the uptake of 440 essential amino acids by GAS might be a feasible strategy to control GAS 441 infection pathology, but further studies are required to test this idea. 442
We identified several virulence-related transporters with unclear functions. 443
One example is the putative ABC transporter comprised of Spy1726 (transporter 444 permease protein), Spy1727 (ATP-binding protein), and Spy1728 (substrate-445 binding lipoprotein). The TraDIS screen results and the virulence phenotype of 446 the isogenic mutant strain indicate this ABC transporter of unknown function is 447 critical for the ability of GAS to cause NHP skeletal muscle pathology. Although 448 its function is not known, multiple additional leads indicate ABC transporter 449
Spy1726-1728 plays a role in host-pathogen interactions. For example, the 450 Spy1726-1728 operon is upregulated when GAS cells are in human blood and 451 macrophages (80, 81). In addition, Spy1726-1728 is regulated by the CovR/S 452 two-component system, a global virulence gene regulator in GAS (82). Proteomic 453 studies show that the substrate-binding lipoprotein Spy1726 is located on the 454 bacterial cell surface, and thus might be a candidate for vaccine or other 455 translational research (70). Future structural and functional studies on this 456 transporter appear to be warranted. 457
To summarize, in this work we used two distinct transposon mutant 458 libraries made in serotypes of GAS that cause abundant human cases of severe 459 invasive infections to identify genes contributing to GAS fitness in an NHP model 460 of necrotizing myositis. NHP infection using six isogenic mutant strains 461 confirmed the crucial requirement for the genes identified by our TraDIS screens. 462
Our findings complement work conducted with other transposon mutant screens 463 that identified GAS genes contributing to fitness during growth in vitro, in human 464 saliva and human blood ex vivo, and mouse subcutaneous infection. The findings 465 presented herein may ultimately lead to better ways to diagnose, treat, and 466 prevent necrotizing myositis and fasciitis caused by GAS, infections with 467 devastating consequences to the human host. These two strains have wild-type alleles of all major transcriptional regulators 476 known to affect virulence, such as covR and covS, ropB, mga, and rocA. 477 GAS strain growth conditions. The GAS strains were cultured in Todd-478
Hewitt broth supplemented with 0.5% yeast extract (THY). When required, GAS 479 strains were grown in a chemically defined medium (CDM) (79). Amino acids 480 were added to the designated concentration. For growth in medium with a 481 carbohydrate source other than glucose, GAS strains were cultured in maltose 482 medium and maltodextrin medium. The composition of these media is presented 483
in Table S8 . 484
Transposon mutant libraries and culture conditions. The mutant library 485 generated in serotype M1 strain MGAS2221 using transposon plasmid 486 pGh9:ISS1 was recently described (31, 49) . The serotype M28 strain 487 MGAS27961 transposon mutant library was made by essentially identical 488 methods. The strains were grown in Todd-Hewitt broth supplemented with 0.2% 489 yeast extract (THY) broth at 37 o C with 5% CO 2 . 490
Preparation of transposon mutant library frozen stock for nonhuman 491 primate infection. 100 µl of the stock transposon mutant library (M1 or M28 GAS 492 library) was inoculated in 500 ml THY supplemented with 0.5 µg/ml erythromycin 493 and cultured at 37 o C for 8 hrs. The proliferated transposon library was pelleted 494 by centrifugation, washed three times with saline, and then suspended in 10 ml 495 saline supplemented with 20% glycerol. The suspended mutant library was 496 aliquoted into cryogenic tubes and stored at -80 o C until subsequent use in NHP 497
infections. 498
Nonhuman primate necrotizing myositis infection model used for TraDIS 499 analysis. A well-described NHP model of necrotizing myositis was used (18, 33) . 500
For the transposon mutant library screens, six cynomolgus macaques (1-3 years, 501 2-4 kg, males and females) each were used for the serotype M1 and M28 502 screens. Briefly, NHPs were sedated and bacteria were inoculated in the right quadriceps. Animals were observed and necropsied 24 hours post-infection. To 504 analyze the output transposon insertion library, a ~0.5 g (~0.5-1.0 cm diameter) 505 biopsy of necrotic muscle was obtained from the inoculation site, homogenized in 506 1 ml sterile PBS, transferred to 40 ml Todd Hewitt broth and incubated for 6 hrs. 507
Before incubation, 100 µl were removed from the 40 ml culture, serially diluted in 508 sterile PBS and plated to determine the number of CFUs in the output library. 509
Infected tissue was also collected for histologic examination. The inoculum used 510 for the input M1 transposon mutant library was ~5x10 8 CFU/kg. The inoculum 511 used for the input M28 transposon mutant library was 1x10 10 CFU/kg. A higher 512 dose of the M28 input transposon mutant library was used because in previous 513 NHP studies, an approximately 10-to-100-fold higher inoculum of M28 strains 514 compared to M1 strains was needed to generate similar disease character. 515 DNA preparation and massively parallel sequencing. The mutant library 516 genomic DNA preparation and DNA sequencing were performed according to 517 procedures described previously for TraDIS analysis (31, 49) . The PCR-amplified 518 libraries were sequenced with a NextSeq550 instrument (Illumina) using a single-519 end 75-cycle protocol. 520
Processing of TraDIS sequencing reads and data analysis. The 521 processing of TraDIS reads and data analysis were performed according to 522 previously described procedures (31). Briefly, the multiplexed raw Illumina reads 523 obtained from the input and output mutant pools were parsed with FASTX 524
Barcode Splitter (http://hannonlab.cshl.edu/fastx_toolkit/commandline.html). The 525 resulting sequencing reads were analyzed with the TraDIS toolkit (83). 526 tradis_comparison.R was used to compare the reads mapped per gene between 527 the input pools (mutant libraries before NHP infection) and the output pools 528 (mutant libraries recovered from infected NHP). The GAS genes with significantly 529 changed mutant frequency (log2 fold-change greater than +/-1, and q value < 530 0.01) in the output mutant pools were interpreted as contributing to GAS fitness 531 during NHP necrotizing myositis. Illumina sequencing reads of the M1 input 532 library (n = 6), M1 output library (n = 6), M28 input library (n = 6), and M28 output 533 library (n = 6) are deposited in the NCBI Sequence Read Archive (SRA) under 534 the accession number (xxxxxxxxxx). 535
Construction and characterization of isogenic mutant strains. Isogenic 536 mutant strains were derived from wild-type parental strain MGAS2221, the 537 organism used for construction of the serotype M1 transposon mutant library. 538
Primers used for generating the mutant strains are listed in Table S7 . Markerless 539 isogenic mutant strains were constructed by nonpolar deletion of the target 540 gene(s) using allelic exchange (18). For example, to delete Spy0014, primer sets 541 0014-1/2 and 0014-3/4 were used to amplify two ~1.5 kb fragments flanking 542
Spy0014 with genomic DNA purified from serotype M1 strain MGAS2221. The 543 two flanking fragments were combined by overlap-extension PCR with primers 544 0014-1 and 0014-4. The combined fragment was cloned into suicide vector 545 pBBL740 and transformed into parental strain MGAS2221. The plasmid integrant 546 was used for allelic exchange as described previously (18) . PCR was used to 547 identify potential mutant candidates containing the desired deletion. All other 548 isogenic mutant strains were generated using analogous methods. Whole 549 genome sequencing of all isogenic mutant strains was done to confirm the 550 absence of spurious mutations. 551
Infection of NHPs with isogenic mutant strains. To confirm the role of 552 candidate genes in necrotizing myositis molecular pathogenesis and thereby 553 validate the TraDIS data, the virulence of the parental wild-type strain 554 MGAS2221 and the six isogenic deletion-mutant strains was assessed in the 555 NHP necrotizing myositis infection model. Animals randomly assigned to 556 different strain treatment groups received 10 8 CFU/kg of one strain (wild-type or 557 isogenic mutant) in the right limb and a different strain in the left limb. Each 558 strain was tested in triplicate. The animals were observed continuously and 559 necropsied at 24 hrs post-inoculation. 560
Histopathology analysis. For histology evaluation, lesions were excised, 561 and visually inspected. Lesions (necrotic muscle) were measured in three 562 dimensions and volume was calculated using the formula for an ellipsoid. Tissue 563 taken from the inoculation site was trisected, fixed in 10% phosphate buffered 564 formalin, and embedded in paraffin using standard automated instruments. 565
Histology of the three sections taken from each limb was scored by a pathologist 566 blinded to the strain treatment groups as described previously (18, 19) . To obtain 567 the quantitative CFU data, diseased muscle obtained from the inoculation site or 568 distal hip margin was weighed, homogenized (Omni International) in 1 mL PBS, 569 and CFUs were determined by plating serial dilutions of the homogenate. 570
Statistical differences between strain groups were determined using the Mann-571
Whitney test.
Iodine staining of wild-type and ΔglgP mutant strain. The wild-type strain 573 and isogenic ΔglgP mutant strain were cultured for eight hours in 10 ml of THY 574 supplemented with 2g/L of soluble starch (Sigma-Aldrich). GAS cells were 575 pelleted and washed five times with saline to remove the culture medium. After 576 the final saline wash, GAS cells were suspended in 1ml of saline. 10 µl of Gram's 577 iodine solution was added to the cell suspensions to visualize glycogen 578 accumulation in the GAS cell. Only the ΔglgP mutant strain displayed a dark blue 579 iodine stain phenotype. 580
Isolation of total RNA from GAS-infected non-human primates quadriceps 581 muscle sections and skeletal muscle from a human with GAS necrotizing 582 fasciitis. Infected tissue from NHPs or human patients was stored at -80°C in 583 DNA/RNA Shield (Zymo Research) or RNAlater (Invitrogen), respectively, 584 thawed on ice, transferred to a tube containing 2 ml of cold TE, and diluted with 585 either 2 ml or 1.3 ml 2X DNA/RNA Shield. Tissue samples were homogenized 586 with an Omni TH homogenizer (Omni International). Prior to lysis the 587 supernatants were divided into either four aliquots each containing 900 µl, or 3 588 aliquots each containing 950 µl, for NHP or human samples, respectively. The 589 tissues were lysed by ballistic disintegration using a FastPrep-96 instrument (MP 590 Biomedicals) and Zymo tubes containing 0.1 and 0.5-mm ZR BashingBeads 591 (Zymo Research). Lysis was repeated three times at 1,600 rpm for 1 min, and 592 tubes were placed on ice for 1 min after each lysis step. Particulate matter 593 present in the supernatants was eliminated with QIAshredder homogenizers 594 (Qiagen). RNA was isolated using the Zymobiomics RNA kit (Zymo Research) 595 following the manufacturer instructions with the exceptions that all aliquots from a 596 particular sample were pooled together before passing them through the first 597 column and the recommended DNase treatment was performed twice for the 598 human samples. Total RNA quality was assessed with an RNA Nanochip and an 599 Complexity of the (A) M1 GAS mutant pools and (B) M28 GAS mutant pools 682 before and after a 24-hr experimental NHP infection. Genome-scale summary of 683 the changes in mutant abundance (y axis) for each of the genes (x axis) in the 684 (C) M1 GAS output pools and (D) M28 GAS output pools. Gene mutations 685
(insertions) conferring significantly decreased (blue dots) or increased (gold dots) 686
fitness are highlighted. of the identified GAS in vivo fitness genes during necrotizing myositis. (E, F) 696
Distribution of the M1 and M28 GAS genes required for infection among the 62 697 sequenced GAS genomes. COG, clusters of orthologous groups. 698 699 and ΔSpy0271-0273 in rich medium THY (A), chemically defined medium (B), 743
and chemically defined medium supplemented with 10g/L tryptone (C). (D-F) 744
Growth of three mutant strains in CDM supplemented with 1g/L of specified 745 amino acids. Experiments were performed in triplicate on 3 separate occasions. 746
Replicate data are expressed as the mean ± SD in D, E, and F. *P < 0.05 vs. 747
unsupplemented group, one-way ANOVA. 
